Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Receivables (2023 - 2025)

Cannabis Bioscience International Holdings' Receivables history spans 3 years, with the latest figure at $21811.0 for Q4 2025.

  • For Q4 2025, Receivables rose 57.83% year-over-year to $21811.0; the TTM value through Nov 2025 reached $21811.0, up 57.83%, while the annual FY2025 figure was $15535.0, 22.86% down from the prior year.
  • Receivables for Q4 2025 was $21811.0 at Cannabis Bioscience International Holdings, up from $18121.0 in the prior quarter.
  • Across five years, Receivables topped out at $21811.0 in Q4 2025 and bottomed at $2640.0 in Q1 2025.
  • The 3-year median for Receivables is $17108.5 (2024), against an average of $15563.6.
  • The largest annual shift saw Receivables soared 102.38% in 2024 before it tumbled 84.51% in 2025.
  • A 3-year view of Receivables shows it stood at $19403.0 in 2023, then fell by 28.78% to $13819.0 in 2024, then skyrocketed by 57.83% to $21811.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Receivables are $21811.0 (Q4 2025), $18121.0 (Q3 2025), and $15535.0 (Q2 2025).